jcm-logo

Journal Browser

Journal Browser

The Emerging Role of the Vagal Nerve in Cardiac, Cerebrovascular and Oncological Diseases

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".

Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 1010

Special Issue Editor


E-Mail Website
Guest Editor
Department of Nursing, University of Haifa, Haifa 677539385, Israel
Interests: neuroimmunology; psychoneuroimmunology

Special Issue Information

Dear Colleagues,

Among the major non-communicable global burden of diseases (GBDs) are cardiac diseases, stroke and cancer. One important issue about these diseases is their multifactorial risk factors and etiological pathologies. Key to understanding and treating them is identifying a factor that can influence several of the etiological processes that lead to these diseases. This Special Issue will apply knowledge from neuroimmunology and will focus on the vagal nerve, in order to progress the understanding, prediction and possible treatment of these GBDs. I invite you all to contribute to this Special Issue with a manuscript that examines the role of the vagal nerve in cardiac, cerebrovascular or oncological diseases. A contributing manuscript can examine the process of predicting the onset or prognosis of these diseases by vagal nerve activity, how the vagus may affect their underlying mechanisms or how it can treat these diseases. I hope that this manuscript will contribute to predicting and treating GBDs.

Prof. Dr. Yori Gidron
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • global burden of diseases
  • heart disease
  • stroke
  • cancer
  • COVID-19
  • vagal nerve
  • neuroimmunology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop